Comment on

• The 2012 hormone therapy position statement of: The North American Menopause Society.

  North American Menopause Society. North American Menopause Society. Menopause. 2012 Mar;19(3):257-71. doi: 10.1097/gme.0b013e31824b970a. Menopause. 2012. PMID: 22367731 Free PMC article.
• We do not agree with the 2012 statement’s recommendation of long-duration HT use that may last until the age of 51 years (or longer if needed for symptom management).

  Chen RJ, Chou CH, Chang TC. Chen RJ, et al. Menopause. 2013 May;20(5):587. doi: 10.1097/GME.0b013e31828f0f0a. Menopause. 2013. PMID: 23615652 No abstract available.